Journal Watch - Hemodialysis

« Back to Most Recent

  • Mobile Health Readiness of Home vs. In-Center Dialysis Patients

    Smartphones and other mobile devices can be used to deliver health messages. In a survey of 949 patients from 14 home and 21 in-center dialysis clinics, 81% had mobile devices to get online, and 72% used the Internet, some (18%) despite concerns about data privacy and security. Younger, non-Hispanic, and more educated patients were more likely to use mobile health, and working patients had the highest rates of proficiency. After adjustment, in-center and home patients were equally proficient with mobile health.

    Read the abstract » | (added 2021-01-12)

    Tags: Kidney Disease, Hemodialysis, Telehealth, Telemedicine

  • Chevron and Butterfly Taping Reduces Venous Needle Dislodgement in HD

    Every clinic seems to have its own preferred method of taping HD needles to prevent dislodgement. This important new study tested Chevron, Butterfly and Overlapping tape patterns in a mechanical engineering laboratory to measure the adhesive force and ability to withstand dislodgement and lateral stress.

    Read the abstract » | (added 2021-01-12)

    Tags: Dialysis, Hemodialysis

  • Converting In-center HD Patients to Home: the Importance of Belief

    A small, cross-sectional study (n=44) interviewed patients who were and were not considering home HD. Only 68% of patients said they’d heard about the benefits of home HD. The cohort who were willing to consider it were significantly more likely to believe that self-care and home HD would improve their quality of life, particularly travel, better health outcomes, and the comfort of being at home.

    Read the abstract » | (added 2020-09-11)

    Tags: Home Hemodialysis, Hemodialysis, Homedialysis, HD

  • Does Extended Hour HD Helps Survival After Returning to Standard HD?

    In an analysis of data from the ACTIVE Dialysis Trial, 200 standard HD patients were randomly assigned to 12 or 24 hours of treatment per week for a year, with follow up at 24, 36, and 60 months after a return to 12 hours of treatment per week. Long-term survival was not improved.

    Read the abstract » | (added 2020-06-10)

    Tags: Mortality, End Stage Kidney Disease, Hemodialysis, Randomized Controlled Trial